These foods are the heaviest hitters. While GLP-1 drugs have transformed how many people think about weight loss, the ...

Study of almost 28,000 people also identifies genetic variants that raise the risk of gastrointestinal side effects from ...

Eli Lilly’s obesity pill was approved by the FDA, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill ...

Revised diagnostic framework may limit access to early treatment, widen healthcare dispari ...

The once daily, oral glucagon-like peptide-1 receptor agonist was approved based on phase 3 data from ATTAIN-1 and ATTAIN-2.

With a second oral GLP-1 for obesity now approved in the U.S., analysts have set to work parsing the blockbuster potential of ...

The daily pill, called Foundayo, could make it easier for more people to lose weight.

Children with metabolically healthy obesity (MHO) have an increased associated risk for cardiometabolic diseases in young adulthood.

"ACC 2026: Ventyx’s VTX3232 Phase IIa results show anti-inflammatory benefits in obesity" was originally created and ...

Medi-Cal has ended coverage for certain anti-obesity medications, leaving many low-income patients unable to afford ...

The Endocrine Society has concerns of possible delays in care and other problematic areas of The Lancet Commission’s proposed new obesity framework; a Commission author cites ‘conceptual confusions.’ ...

The Gurugram-based obesity surgeon deemed dry fruits as medicine, which, without a proper dose, is poison. Check the right ...